The Trump Administration Is Shifting Federal Policy On Cannabis And Psychedelics

In this week’s edition of InnovationRx, we look at a new drug cost partnership, a brain implant deal, and more.

Continue Reading


News Source: www.forbes.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *